Course 1: Health innovation and entrepreneurship

Learn how to turn research results and ideas into business ventures and how to create innovative services in a clinical setting. 

About the modules

Module 1, Oslo: February 7-9, 2018

Module 2, Trondheim: March 21-23, 2018

Module 3, Stockholm: April 18-20, 2018


Dropbox for presentations e.g. (admission for students)

About the course

The course will equip medical, healthcare and life science researchers with tools and knowledge to innovate services for patients, create companies based on their research ideas, or bring their research ideas into existing companies.

You will meet with and learn from leaders in academia, hospitals and healthcare Companies.

A core part of the course is case-based work where the cases are developed in collaboration between the universities and companies. In addition, the participants will identify and develop potentially commercializable ideas from their own research environment. The teaching language throughout the course is English.


"Health innovation and entrepreneurship" is open for PhD candidates and postdoctors from UiO, NTNU, KI, UiB, UiT, clinicians working at hospitals and other collaborating institutions. The course is open for applications from qualified applicants from medicine, psychology, odontology, technology and natural sciences.

The number of students is limited to 50 and admission is selective.

Include a letter describing your motivation for applying for this course.

The application process is now over, and applicants have been notified by e-mail.

Practical issues and expenses

There is no course fee, and acommodation is booked and covered by HIS for the duration of the course (not the night before or after). Participants who want to stay longer have to book and cover this themselves.

Participants have to book journeys and cover traveling expenses, or apply to own employer or other funder for covering.

HIS covers lunch and dinner. Dinner includes up to 2 glasses wine/beer/mineral water. Additional beverage must be covered by participants due to Norwegian regulations.

Learning outcomes

After completion of the course the participants will be able to:

  • Demonstrate an understanding of the opportunities of health innovation and entrepreneurship for utilization of research.
  • Apply scientific background and knowledge of health innovation to address challenges and develop services and products within a clinical setting and a biopharma/medtech setting.
  • Use various business tools for ideation and feasibility studies; to develop, prototype and test solutions to user needs.
  • Develop a business plan based upon a novel idea and communicate a business plan to people within the startup world.
  • Demonstrate an understanding of how the Tech Transfer Office and other innovation support actors can support the commercialization process.
  • Apply the basics in financing a startup company from private and governmental funding bodies.
  • Discuss and argue for different types of intellectual property and intellectual assets, and establish patent strategies.
  • Assess their skills in health innovation and reflect on the exploitation of their own research.
  • Combine being a scientist and a health innovator/entrepreneur.
  • Gain familiarity of principles for open innovation. Enabling, initiating and managing knowledge flows for generating open innovation in sciences.


You must attend at least 80 per cent of the course in order to be allowed to take the exam. Attendance will be registered.

The examination will be based on the following:

  • Oral group presentations related to cases
  • Group innovation project presented at the end of the course.The project may be based from your own research or developed during the course.
  • Written individual report (2-3 pages) in which you reflect on your main learning outcomes from the course and how you may utilize this new learning in your career.

The grading is based on the pass/fail system.
The course gives 7.5 ECTS.


The course is a Norwegian/Swedish enterprise developed in partnership between:

  • The University of Oslo (UiO)
  • Norwegian University of Science and Technology (NTNU)
  • Karolinska Institutet (KI) in Stockholm
  • The healthcare business clusters Nansen Neuroscience Network

It is developed in collaboration with:

  • The University of Bergen (UiB)
  • The University of Tromsø (UiT)
  • Oslo Cancer Cluster and Norway healthtech
  • UiO:Life Science
  • The Research Council of Norway
  • South-Eastern Norway Regional Health Authority

The course is open to applicants from all collaborating universities and institutions.


The application deadline was December 31 2017. Applicants for the programme has been notified by e-mail.


With financial support from

Norwegian Research Council


Questions? Please contact Bjarte Reve at

Published Oct. 19, 2016 11:21 AM - Last modified Apr. 13, 2018 12:01 PM